The enrichment results of GO and KEGG suggested that the mechanisms of different ginseng derived products in the treatment of HF were mainly related to pathways in cancer, PI3K-Akt pathway, Ras pathway, apoptosis, and mTOR pathway and other pathways, which shows that different derived products of ginseng have the characteristics of multi-target and multi-pathway in the treatment of HF. The gene discussed is MTOR; the disease is hydrops fetalis.